75
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Expression and prognostic impact of NTF3 and TrkC in hepatocellular carcinoma

, , , &
Pages 1309-1316 | Received 03 Apr 2023, Accepted 20 May 2023, Published online: 05 Jun 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
  • Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020;1873(1):188314.
  • Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609–642.
  • Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736.
  • Feng Q, Song D, Wang X. Pan-cancer analysis reveals that neurotrophin signaling correlates positively with anti-tumor immunity, clinical outcomes, and response to targeted therapies and immunotherapies in cancer. Life Sci. 2021;282:119848.
  • Meldolesi J. Neurotrophin Trk receptors: new targets for cancer therapy. Rev Physiol Biochem Pharmacol. 2018;174:67–79.
  • Al-Yozbaki M, Acha-Sagredo A, George A, et al. Balancing neurotrophin pathway and sortilin function: its role in human disease. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188429.
  • Jin W. Roles of TrkC signaling in the regulation of tumorigenicity and metastasis of cancer. Cancers. 2020;12(1):147.
  • Detre S, Saclani Jotti G, Dowsett M. A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 1995;48(9):876–878.
  • Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
  • Okamura R, Boichard A, Kato S, et al. Analysis of NTRK alterations in pan-cancer adult and pediatric malignancies: implications for NTRK-targeted therapeutics. J Clin Oncol Precis Oncol. 2018;2018:PO.18.00183.
  • Choi S, Park S, Cho YA, et al. Clinical significance of Trk receptor expression as a new therapeutic target in hepatocellular carcinoma. Pathol Oncol Res. 2020;26(4):2587–2595.
  • Jin W, Lee JJ, Kim MS, et al. DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2011;406(1):89–95.
  • Yang Z, Zhang H, Yin M, et al. Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways. Int J Biol Sci. 2022; 18(15):5963–5977.
  • Yang QX, Liu T, Yang JL, et al. Low expression of NTF3 is associated with unfavorable prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol. 2020;13(9):2280–2288.
  • Liu R, Li R, Yu H, et al. NTF3 correlates with prognosis and immune infiltration in hepatocellular carcinoma. Front Med. 2021;8:795849.
  • Amatu A, Sartore-Bianchi A, Bencardino K, et al. Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer. Ann Oncol. 2019;30(Suppl_8):viii5–viii15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.